ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
RCPI was delisted on the 4th of November, 2015.
3 hedge funds and large institutions have $109K invested in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
46% less capital invested
Capital invested by funds: $203K → $109K (-$94.4K)
67% less funds holding
Funds holding: 9 → 3 (-6)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kempner Capital Management
Galveston,
Texas
|
+$29.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$20K |
| 2 |
IWMPD
Integrated Wealth Management (Palm Desert)
Palm Desert,
California
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Kempner Capital Management
Galveston,
Texas
| $69K | +$29.1K | +80,000 | +73% |
|
|
2
Ameriprise
Minneapolis,
Minnesota
| $40K | -$20K | -55,428 | -33% |
|
|
IWMPD
3
Integrated Wealth Management (Palm Desert)
Palm Desert,
California
| – | -$1K | -912 | Closed |
|
RCPI Hedge Fund Activity: Q1 2016 in Review
3 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) for Q1 2016, worth a combined $109K — down 46% from $203K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of RCPI and 0 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Kempner Capital Management, adding an estimated $29.1K. The largest seller was Ameriprise, cutting an estimated $20K.
- 3 institutional investors held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) as of Q1 2016, down from 9 in Q4 2015.
- Funds reported $109K of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) stock for Q1 2016, down 46% quarter-over-quarter.
- 0 funds opened new ROCK CREEK PHARMACEUTICALS INC COM STK (DE) positions in Q1 2016 and 5 closed out, a net change of -5 holders.
- The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2016 was Kempner Capital Management, an estimated $29.1K added.
- The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) seller in Q1 2016 was Ameriprise, an estimated $20K sold.
Based on aggregated 13F filings for Q1 2016.